• FOLLOW US
Video Player
  • Email
  • share

Tonix CEO: Investors Seeing Value in Reformulation Strategy

Shares of Tonix Pharmaceuticals are up over 35% in 2014 because investors are finally starting to appreciate the company's story, says Tonix CEO Dr. Seth Lederman. The biotech, which raised $43 million in a January secondary, is working on prescripti

http://www.wgrz.com/video/3216684417001/1/Tonix-CEO-Investors-Seeing-Value-in-Reformulation-Strategy http://cdn.newslook.com/da/da2a47e4fd7aadd445efc28c4fce31fc/images/frame_ext.jpg Tonix CEO: Investors Seeing Value in Reformulation Strategy Shares of Tonix Pharmaceuticals are up over 35% in 2014 because investors are finally starting to appreciate the company's story, says Tonix CEO Dr. Seth Lederman. The biotech, which raised $43 million in a January secondary, is working on prescripti FinanceyoutubeYahoo!newslook 02:51

Next Up

    

More Videos

Recent Videos

Page 1 of 7
The Grand Canyon Of Pennsylvania

The Grand Canyon Of Pennsylvania

03:18 | 8/2/2015 8:19:24 AM
Adopt A Pet: Dilinger

Adopt A Pet: Dilinger

03:07 | 8/2/2015 8:18:34 AM
Latest Storm Team 2 Forecast

Latest Storm Team 2 Forecast

02:16 | 8/2/2015 7:34:54 AM
sun am webwx

sun am webwx

02:16 | 8/2/2015 7:32:15 AM
080215-rexonpercy

080215-rexonpercy

01:30 | 8/2/2015 12:02:41 AM